However, for the transfer of such preclinical data to human COPD, delineation of the exact signaling mechanism of lung regeneration upon iNOS inhibition and the identification of responsible cell type(s) is necessary, as they could have a large impact on the therapeutic strategy (e.g., preferred route of administration, duration of treatment). Here, NOS2 is linked to chronic obstructive pulmonary disease.